THE SIZE OF CLINICAL-TRIALS IN CANCER-RESEARCH - WHAT ARE THE CURRENT NEEDS

被引:21
作者
FREEDMAN, LS [1 ]
机构
[1] MRC,CANC TRIALS OFF,5 SHAFTESBURY RD,CAMBRIDGE CB2 2BW,ENGLAND
关键词
D O I
10.1038/bjc.1989.79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:396 / 400
页数:5
相关论文
共 21 条
  • [2] BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO
  • [3] 2-C
  • [4] AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA
    CORTES, EP
    HOLLAND, JF
    WANG, JJ
    SINKS, LF
    BLOM, J
    SENN, H
    BANK, A
    GLIDEWELL, O
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 998 - 1000
  • [5] CURRENT STATUS OF INTRAVESICAL CHEMOTHERAPY TRIALS IN THE EORTC-UROLOGICAL-GROUP - AN OVERVIEW
    DENIS, L
    BOUFFIOUX, C
    KURTH, KH
    DEBRUYNE, F
    SYLVESTER, R
    DEPAUW, M
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 : S67 - S71
  • [6] EILBER FR, 1978, CANCER TREAT REP, V62, P213
  • [7] ELLENBERG SS, 1985, CANCER TREAT REP, V69, P1147
  • [8] HAYBITTLE J, 1988, BRIT J CANCER, V57, P521
  • [9] ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA
    JAFFE, N
    FREI, E
    TRAGGIS, D
    BISHOP, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 994 - 997
  • [10] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY
    LINK, MP
    GOORIN, AM
    MISER, AW
    GREEN, AA
    PRATT, CB
    BELASCO, JB
    PRITCHARD, J
    MALPAS, JS
    BAKER, AR
    KIRKPATRICK, JA
    AYALA, AG
    SHUSTER, JJ
    ABELSON, HT
    SIMONE, JV
    VIETTI, TJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) : 1600 - 1606